ADHD Trial, Recruiting (NCT07042347)

ADHD Trial, Recruiting NCT07042347 Sponsor: University of Pennsylvania Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT07042347 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Aides (support workers) who are currently working one-on-one with at least one child or young person in a school setting, where that child is between 3 and 17 years old, has a diagnosis linked to challenging behaviour (such as autism spectrum disorder, ADHD, or oppositional defiant disorder) noted on their treatment plan, and receives individual aide support.
Supervisors who are employed by a community mental health or behaviour health agency and who directly supervise an aide who is also participating in the trial — the trial is looking to enrol supervisors and aides in pairs (one supervisor paired with one aide), with a total of 30 such pairs.

Who may not be able to join:

Aides who took part in an earlier pilot version of the Footsteps trial, as the trial is looking to include people who have not previously used the Footsteps program or the comparison app.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Heather J Nuske, PhD, University of Pennsylvania

Phone: (215) 746-6041

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07042347

Sponsor: University of Pennsylvania

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: (215) 746-6041

More information: https://clinicaltrials.gov/study/NCT07042347

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Aides (support workers) who are currently working one-on-one with at least one child or young person in a school setting, where that child is between 3 and 17 years old, has a diagnosis linked to challenging behaviour (such as autism spectrum disorder, ADHD, or oppositional defiant disorder) noted on their treatment plan, and receives individual aide support.
Supervisors who are employed by a community mental health or behaviour health agency and who directly supervise an aide who is also participating in the trial — the trial is looking to enrol supervisors and aides in pairs (one supervisor paired with one aide), with a total of 30 such pairs.

Who may not be able to join:

Aides who took part in an earlier pilot version of the Footsteps trial, as the trial is looking to include people who have not previously used the Footsteps program or the comparison app.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Pennsylvania

Registry

ClinicalTrials.gov

Start date

8 April 2026

Est. completion

30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Strengths and Difficulties Questionnaire total score; Data collection consistency; Data collection timeliness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov